
Gut toxins and 50,000 deaths: The truth behind the rise in colon cancer and the signs to look for
Colorectal cancer rates are rising among younger Americans - the reason behind the jump has become hard for scientists to identify, but the symptoms to watch out are known.
Colorectal cancer, which encompasses colon and rectal cancer, is the second leading cause of all cancer-related deaths in the U.S. Last year saw a slight increase in deaths, with just over 53,000 reported. There were also nearly 153,000 new cases of colorectal cancer, the majority of which were in men. While survival rates have improved among older Americans, the incidence rate for people under the age of 55 continues to rise by between 1 and 2 percent, according to the Colorectal Cancer Alliance. The trend has been reported since the mid-1990s.
The mortality rate has also increased by about 1 percentage point each year since the mid-2000s. If current trends continue, colorectal cancer is slated to become the leading cause of cancer-related death among young adults in the next five years.
Now, a new study has identified a potential link between a toxin in the gut and the sharp rise of disease in younger people. Colibactin, which is produced by harmful species of gut bacteria, can inflict DNA damage on colon cells that can lead to the development of cancer.
Researchers say that damage is prominent in people who developed colorectal cancer at a younger age. Previous research had identified the DNA mutations in approximately 10 to 15 percent of all colorectal cancer cases.
'These mutation patterns are a kind of historical record in the genome, and they point to early-life exposure to colibactin as a driving force behind early-onset disease,' UC San Diego professor Ludmil Alexandrov explained in a statement.
So, what should Americans know about this toxin?
E. coli — yes, the foodborne illness E. coli — is a vital part of a healthy gut microbiome. However, some strains can produce the toxin called colibactin, which is capable of altering a person's DNA.
The toxin has been previously been linked to some cases of colorectal cancers, and 20 percent of people are thought to contain strains that can produce it.
But, colibactin-producing microbes are not the only bacteria linked to colorectal cancers. Another gut microbe called F. nucleatum has been implicated in the development of the disease.
It may contribute to disease development by enabling the tumor to proliferate and evade the immune system, Alexandrov told NBC News.
When should people look out for impacts from colibactin?
Colibactin's damaging effects begin early on. Alexandrov and the study's authors found such mutations occur within the first 10 years of life.
Furthermore, the study revealed that DNA mutations account for approximately 15 percent of mutations found in the tumor-suppressing APC gene in colorectal cancer, which are some of the earliest genetic changes that can directly promote cancer development.
'If someone acquires one of these driver mutations by the time they're 10 years old,' Alexandrov said, 'they could be decades ahead of schedule for developing colorectal cancer, getting it at age 40 instead of 60.'
What are the symptoms to be aware of?
Although some people could have colon cancer and not know it, others may experience blood in their stool, diarrhea, fatigue, rectal bleeding, constipation, abdominal pain, a change in bowel habits and unexplained weight loss.
Colorectal polyps that grow in the colon or rectum can turn into cancer if not removed.
If you are experiencing a symptom, it does not mean you have colorectal cancer. But, you should see a doctor.
'If anyone has any change in their bowel habits, if they have any bleeding — even if they think it's a hemorrhoid, and it doesn't go away — just get a colonoscopy,' Yale Medicine colorectal. surgeon Dr. Vikram Reddy advised.
Why are colorectal cancer rates rising in young people?
Young people are often diagnosed with more advanced cancers due to delays in detection.
'If you're 39 and you're having these symptoms, you're not thinking, 'I have colon cancer,'' Dr. Sonia Ramamoorthy, chief of colorectal surgery at UC San Diego said. 'You're thinking, 'I ate something. I'm working too hard.' If you're tired and you're stressed out, you're thinking, 'It'll go away.' People are presenting later because they're just not attributing their symptoms to something that could be serious.'
But, doctors have also singled out other contributing factors, including excess body weight, a sedentary lifestyle, smoking, a high intake of red or processed meat, and other environmental factors.
A family history of colorectal cancer or polyps, and conditions such as inflammatory bowel disease, are also risk factors, according to Yale Medicine.
How do I protect myself?
People may reduce their risk of colorectal cancer by limiting their alcohol consumption, keeping a healthy diet and increasing their physical activity.
Screenings also play an important role in finding any precancerous polyps before they turn into cancer.
Federal health officials say people should get screened starting at age 45, although there are questions about whether it should be lowered to 40. Those with a family history of colorectal cancer may need to get checked even earlier. Although, screening comes with its own risks as some medical machines have been linked to higher cancer rates.
There are some disparities to be aware of - Black Americans are 15 percent more likely to develop colorectal cancer and 35 percent more likely to die from it than white Americans.
But, there's still a lot to learn.
'We don't understand a lot about the causes, the biology, or how to prevent early onset of the disease,' Phil Daschner, a program director in NCI's Division of Cancer Biology said. 'And that's important to learn more about because it may affect [approaches for] the treatment and survivorship of early-onset colon cancer.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mail
18 hours ago
- Daily Mail
EXCLUSIVE Popular supplements everyone takes that raise the risk of Alzheimer's
One in two Americans are now expected to develop dementia in their lifetime, with the number of new cases soaring at an alarming rate. Many of us already know that making simple healthy choices such as eating well and staying active can help stave off the disease. Your browser does not support iframes.


NBC News
19 hours ago
- NBC News
Crushed by Israeli missile strikes, Gaza's hospitals are barely functioning
Israeli military assaults on the Gaza Strip's hospitals have ramped up in recent weeks to the highest level so far this year, bringing a health system already weakened by 19 months of war to a breaking point. NBC News has analyzed 27 videos and images from the last two months taken by civilians and our own journalists on the ground to piece together a picture of the full extent of the destruction of a health system engulfed in war. In footage from a surveillance camera, men, women and children could be seen crossing the entrance to Khan Younis' European Hospital moments before a missile hit, blasting people into the air as others scattered in panic. Another video, posted to social media and verified by NBC News, showed the fiery aftermath of an explosion at a medical warehouse near Al-Awda Hospital, in northern Gaza, which has been attacked repeatedly, including on May 22 and again on May 24. 'Nearly all hospitals in Gaza are now damaged or destroyed, and half of them are no longer operational,' Jens Laerke, spokesperson for the United Nations Office for the Coordination of Humanitarian Affairs, or OCHA, told NBC News. During the war, Gaza's hospitals have eked back services, only to be repeatedly struck or besieged again. Hospitals are protected under international humanitarian law, butIsrael has maintained that Hamas uses hospitals and medical centers for military activities, opening them to attack. Hamas has denied doing so. Humanitarian groups, including the United Nations, havesaid Israel has not provided sufficient information to substantiate many of its claims and have called for independent investigations of Israel's attacks and Hamas' alleged misuse of the facilities. Earlier this week, however, the Israeli military gave a small group of reporters a tour of a tunnel that was uncovered beneath the European Hospital, where it said it had recovered the body of Hamas' military chief Mohammed Sinwar. 'We cannot stress this enough: Hospitals must never be militarized or targeted. If they are, it may constitute a war crime,' Laerke said. Of Gaza's 36 hospitals, none are fully functioning; 17 are providing partial services, and 19 are not functioning at all, according to World Health Organization data from Monday. The wider health system, including ambulances, field hospitals and clinics, has been attacked more than 700 times since the start of the war, killing at least 900 people and injuring more than 1,000. (The death toll across Gaza is more than 55,000, according to the health ministry.) After a ceasefire was called in January, Israeli military attacks on Gaza's health system had abated. The truce fell apart in March, and WHO data shows a ramping up of attacks in recent weeks. While the organization tallied five attacks on Gaza's health system in April, after the first three weeks of May, the number of attacks had quadrupled to 21, with at least three more attacks since, including on the vicinity of a dialysis center at the Indonesian Hospital on June 1 and strikes on Al-Aqsa and Al-Ahli Hospitals on June 4 and 5. In addition, hostilities near Al-Amal Hospital have rendered it 'out of service,' the WHO said Monday. The earliest attack recorded by NBC News during that two-month period was on April 2, when an Israeli airstrike hit a UNRWA clinic in Jabalia, north of Gaza City, that was housing displaced people. Video captured by NBC News on the ground documented the chaotic aftermath: walls crushed to rubble, charred mattresses, furniture blasted into shards. A child's small, shrouded body was loaded onto a donkey cart to be taken to the morgue. In another case, the Israel Defense Forces struck two hospitals on the same day, May 13, both in Khan Younis. Video verified by NBC News shows several large plumes of smoke rising from the grounds of the European Hospital. Palestinian health officials said at least 16 people were killed and dozens more injured. The WHO said the facility had been forced to suspend services. Also struck that day was the Nasser Medical Complex. Video posted by the U.N. showed scattered debris, twisted hospital beds and damaged equipment. It was the fourth time Nasser had been hit during the war, according to the U.N., with the latest strike killing two people and injuring a dozen others. In a statement in response to those attacks, the IDF said its forces had targeted a command and control center located at Nasser Hospital and 'a Hamas underground terrorist infrastructure site' underneath the European Hospital. The IDF provided evidence of what it said was a Hamas tunnel beneath the European Hospital. It did not, however, provide evidence for the command and control center at Nasser, or for the following cases, but broadly said: 'The Hamas terrorist organization continues to use hospitals in the Gaza Strip for terrorist activity.' NBC News is not able to independently verify the IDF's statements.


The Independent
20 hours ago
- The Independent
The cost of staying alive could become a lot more expensive for millions of Americans because of Trump drug tariffs
Americans would likely pay more for necessary everyday prescription drugs, such as insulin, painkillers, chemotherapy, or antibiotics, if President Donald Trump were to enact tariffs on pharmaceuticals, experts warn. In an effort to incentivize drug manufacturers to bring production back to the United States, Trump has proposed tariffing pharmaceuticals made overseas – which account for an overwhelming majority of everyday medicine used in the U.S. 'We're going to be doing that,' Trump said of pharmaceutical tariffs in April. 'That's going to be like we have on cars. You know we have a 25 percent tariff on cars, we have a 25 percent tariff on steel and aluminum, and that's what the [pharmaceutical] category fits right now.' 'The higher the tariff, the faster they come,' Trump said. But experts say that's not necessarily true and there would be tangible consequences to such action, from higher brand-name drug prices to generic drug shortages. 'If tariffs were applied to prescription drugs, one of the most immediate consequences could be price increases — on prices that we already pay way in excess of other countries,' Dr. Mariana Socal, an associate professor at the Johns Hopkins Bloomberg School of Public Health, said. The U.S. imports a majority of its branded prescription drugs – or medications that are patented with a brand name such as Viagra, Wegovy, or Zoloft – from high-income countries. Dr. Jeromie Ballreich, an associated research professor at Johns Hopkins Bloomberg School of Public Health, said much of the manufacturing comes from Ireland, Germany, and Switzerland because they have favorable tax policies for companies. As a result, adding a tariff would only make it more expensive for pharmacies and insurance companies to keep them in supply. 'We would expect pharma to pass the costs onto the insurers and we would expect insurers to pass the cost onto the individual patients,' Ballreich said. 'So, if there is a 50 percent tariff on your insulin product because it's coming from Ireland, patients in Mississippi who get insulin – they will either be faced with a higher cost when they go up to the pharmacy to fill their insulin or they're going to face a higher indirect cost because the premiums of the insurance plan are going to go up,' he said. Ballreich said a tariff on countries that produce high quantities of branded drugs would put 'pressure' on public insurers like Medicare or Medicaid and private insurers. However, branded drugs only account for roughly 10 to 15 percent of prescriptions. A majority of Americans, up to 90 percent, use generic drugs, often manufactured in India and China, because they're cheaper. Making branded drugs less accessible through tariffs would only increase reliance on generic drugs, which could exacerbate shortages that already impact millions of Americans. Generic drugs would become less available '[Shortages] can have very significant implications in day-to-day clinical practice,' Socal said. 'For example, if you are administering chemotherapy for an oncology patient, that may have significant consequences even for the prognosis of that case moving forward.' In 2024, the U.S. experienced a shortage of more than 300 drugs – 70 percent of which were generic prescriptions. Socal said that when patients are not able to access a more affordable version of their prescription, it means they may put their health at risk by skipping a dosage, taking a lower dosage, or not filling their prescription at all. Otherwise, they're forced to turn to the more expensive branded version. 'Those more expensive drugs are not always the best,' Socal said. 'Very frequently, and we saw this with chemotherapy shortages, the available drugs are second-line drugs.' Tariffs won't necessarily increase domestic manufacturing The president has indicated that any negative impact from tariffs may be temporary and worth it to bring manufacturing and jobs back. 'We're doing it because we want to make our own drugs,' Trump said. But Ballreich and Socal are more skeptical. 'Tariffs are a very blunt instrument to incentivize domestic U.S. manufacturing of the branded drugs we use,' Ballreich said. Given pharmaceutical companies have moved outside of the U.S. for tax purposes, Ballreich says tax policy may be a better way to incentivize them, especially since many of those drugs are more difficult to manufacture. 'It's not just a very simple chemical plant; these tend to be very complex,' he said. Socal suggested a better strategy would be to understand where drugs are being manufactured and which ones would make more sense to bring to the U.S. — since even those manufactured locally often rely on certain imported ingredients and materials. 'Having tariffs on pharmaceutical products coming from abroad can actually also hurt our domestic manufacturers,' he says. While the president has not officially implemented any tariff policy on pharmaceuticals yet, he said, in April, that the plan would take effect in the 'not too distant future.'